A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with Gram-negative urosepsis
Michael Luchi(University of Kansas Medical Center), Urosepsis Study Group, Henry F. Chambers(San Francisco General Hospital), Harold C. Wiesenfeld(Magee-Womens Hospital), Gus J. Slotman(Apple (Israel)), Ken Y. Yoneda(University of California Davis Medical Center), David C. Morrison, Jon H. Lemke(University of Iowa), D. B. HORN(Children's Hospital of Philadelphia), John L. Ryan(Pfizer (United States)), Steven M. Opal(Brown University)
Cited by 38
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k